product summary
Loading...
company name :
MyBioSource
product type :
protein
product name :
Cancer Antigen 19-9 (CA 19-9), Human
catalog :
MBS173342
quantity :
5000 Units
price :
150 USD
more info or order :
product information
catalog number :
MBS173342
products type :
Protein
products full name :
Cancer Antigen 19-9 (CA 19-9), Human
products short name :
Cancer Antigen 19-9
products name syn :
Tumor Marker 19-9; CA 19-9; Cancer Antigen 19-9; carbohydrate antigen 19-9; Sialylated Lewis (a) Antigen; Cancer Antigen 19-9 (CA 19-9)
specificity :
Gastrointestinal, Pancreatic Cancer
purity :
Highly Purified
form :
Liquid. Appearance: Clear and Colorless
storage stability :
At -20 degree C
other info1 :
Source: Human Liver Metastases. UNSPSC Code: 51131907
other info2 :
Recertification: 2 years. Activity: Typically >= 500 kU/mL (Roche Elecsys EIA)
products categories :
Proteins; Antigens; Enzymes; Standards/controls; Native Proteins; Cancer Antigen 19-9 (ca 19-9)
products description :
MyBioSource the leading producer and supplier of Cancer Antigen 19-9 (CA 19-9) for pancreatic management research and biomarker for manufacturing. Custom preparations, technical support, bulk quantities and aliquoting available. Cancer Antigen 19-9 is a tumor marker elevated in blood of patients with carcinoma of the gastro-intestinal tract. Primarily used distinguishing pancreatic cancer from pancreatitis, CA 19-9 is not sufficiently specific for use as a cancer screening test. The specificity for pancreatic cancer increases with increasing levels, high levels showing a specificity of >97% for tumor presence. CA 19-9 can be elevated in many types of gastrointestinal cancer, such as colorectal cancer, esophageal cancer and hepatocellular carcinoma. A group of mucin type glycoprotein Sialosyl Lewis Antigens (SLA), such as CA19-9 and CA19-5, have come to be recognized as circulating cancer associated antigens for gastrointestinal cancer. CA19-9 represents the most important and basic carbohydrate tumor marker. The immunohistologic distribution of CA19-9 in tissues is consistent with the quantitative determination of higher CA19-9 concentrations in cancer than in normal or inflamed tissues. Recently reports indicates that the serum CA19-9 level is frequently elevated in the serum of subjects with various gastrointestinal malignancies, such as pancreatic, colorectal, gastric and hepatic carcinomas. Together with CEA, elevated CA19-9 is suggestive of gallbladder neoplasm in the setting of inflammatory gallbladder disease.
size1 :
5000 Units
price1 :
150 USD
size2 :
25000 Units
price2 :
300
size3 :
100000 Units
price3 :
710
more info or order :
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.
"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."
Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...
"MyBioSource offers the best products at unbeatable prices."
Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.
Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!